Ginkgo bioworks announces participation in the morgan stanley 22nd annual global healthcare conference

Boston , aug. 30, 2024 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that chief financial officer, mark dmytruk, is scheduled to participate in a fireside chat at the morgan stanley 22nd annual global healthcare conference on friday, september 6 at 11:30 a.m. et. further details, a webcast link, and a replay of the fireside chat will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.
DNA Ratings Summary
DNA Quant Ranking